Title: Impact of the Enzyme Replacement Therapy, INZ-701, in Children with ENPP1 Deficiency: Experience from an Expanded Access Program Presentation Number: 10 – Poster Session Date: Saturday, ...
Quarterly revenue of $735 million;GAAP loss of ($4.90)/share and adjusted EPS of $0.75DALLAS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare ...
In January, the U.S. Environmental Protection Agency (EPA) released its interim decision under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regarding the use of ethylene oxide (EtO) ...
The University of South Florida will commence its search for a new president in the coming days after President Rhea Law ...
Doctors are pleased that the electronic patient record for all will not get underway until April. By then, shortcomings and ...